TCBPY (TC BioPharm (Holdings)) Current Deferred Taxes Liabilities : $0.00 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is TC BioPharm (Holdings) Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

TC BioPharm (Holdings)'s current deferred tax liabilities for the quarter that ended in Dec. 2024 was $0.00 Mil.

TC BioPharm (Holdings) Current Deferred Taxes Liabilities Historical Data

The historical data trend for TC BioPharm (Holdings)'s Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TC BioPharm (Holdings) Current Deferred Taxes Liabilities Chart

TC BioPharm (Holdings) Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

TC BioPharm (Holdings) Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24	Dec24
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial							-	-	-	-	-

TC BioPharm (Holdings) Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of TC BioPharm (Holdings)'s Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

TC BioPharm (Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TC BioPharm (Holdings) PLC (OTCPK:TCBPY) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR

Website

https://www.tcbiopharm.com

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.

Executives

Renaissance Capital Partners Ltd	10 percent owner	42 SHAD THAMES, LONDON X0 SE1 2YD
Diana Elizabeth Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Kenneth Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Mark Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD